Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.509)

71

Covid-19 : NICE plans to expand Paxlovid eligibility to 1.4 million more people

enthalten in: BMJ (Clinical research ed.) | 2024

von Mahase, E.

72

Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies

enthalten in: Influenza and other respiratory viruses | 2024

von Aiello, T. | Peyrony, O. | Chumbita, M. | +12

73

Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, H. | Zhou, J. | Chen, H. | +10

74

No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

enthalten in: Journal of medical virology | 2024

von Palomino-Cabrera, R. | Tejerina, F. | Molero-Salinas, A. | +9

75

Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID

enthalten in: JAMA | 2024

von Suran, M.

76

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

enthalten in: Expert review of anti-infective therapy | 2024

von Liu, T. | Wu, J. | Huang, P. | +5

77

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing : a multicenter retrospective cohort study

enthalten in: BMC infectious diseases | 2024

von Han, X. | Gao, D. | Li, C. | +18

78

PBPK Modeling of PAXLOVIDTM : Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption Model

enthalten in: Journal of pharmaceutical sciences | 2024

von Jaini, R. | Lin, J. | Di, L. | +1

79

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

80

A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir

enthalten in: Clinical pharmacokinetics | 2024

von Gerhart, J. | Cox, D. | Singh, R. | +6